Related Experiment Video
Updated: Jun 16, 2026
11:52
Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
Published on: January 27, 2023
Inhibitory effect of luteolin on osteoclast differentiation and function.
Ji-Won Lee1, Jae-Yong Ahn, Shin-Ichi Hasegawa
1Department of Biological Chemistry, Chubu University, 1200 Matsumoto, Kasugai, Aichi, 487-8501, Japan.
Cytotechnology
|February 18, 2010
Summary
Luteolin, a natural flavonoid, effectively inhibits osteoclast formation and bone resorption by targeting key signaling pathways. This compound shows promise as an anti-resorptive agent for bone-related conditions.
Area of Science:
- Bone Biology and Osteoclast Differentiation
- Natural Product Chemistry and Pharmacology
Background:
- Osteoclasts are critical for bone resorption, and their dysregulation contributes to bone diseases.
- Targeting osteoclastogenesis is a key strategy for developing anti-resorptive therapies.
Purpose of the Study:
- To investigate the effects of luteolin on receptor activator of nuclear factor-kappaB ligand (RANKL)-induced osteoclastogenesis, function, and signaling.
- To evaluate luteolin's potential as an anti-resorptive agent.
Main Methods:
- Co-culture systems using mouse bone marrow cells and ST2 cells.
- Treatment of osteoclast precursors (bone marrow macrophages, RAW264.7 cells) with luteolin.
- Assessment of osteoclast formation, bone resorption, actin ring integrity, and signaling pathways (p38 MAPK, NFATc1).
Main Results:
- Luteolin significantly inhibited RANKL-induced osteoclastogenesis and bone resorption.
- Luteolin disrupted actin ring formation in mature osteoclasts.
- Luteolin suppressed key signaling molecules ATF2 and NFATc1, downstream of p38 MAPK.
Conclusions:
- Naturally occurring luteolin exhibits potent inhibitory effects on both osteoclast differentiation and function.
- Luteolin acts by inhibiting the RANKL-induced signaling pathway and disrupting actin ring formation.
- Luteolin is a promising candidate for anti-resorptive therapies.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...